Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Using brain stimulation to treat depression in older adults

Official title: Transcranial Direct Current Stimulation for Depression

Run by Taipei Veterans General Hospital, Taiwan · NCT06187454 · Data updated 2026-11-12

This study is testing if a brain stimulation treatment can help older adults with depression who haven't found relief from regular medications.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment30 (estimated)
SponsorTaipei Veterans General Hospital, Taiwan
Government
Locations1 site (Taipei)
StatusRecruiting
StartedSeptember 8, 2020
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 2, 2024
Trial IDNCT06187454 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly individuals diagnosed with major depression who have not benefited from antidepressant medications.

Probably not a fit

Patients with severe depression, a history of ineffectiveness with tDCS, or those with contraindications for the treatment will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the efficacy and safety of transcranial direct current stimulation (tDCS) as an additive treatment for elderly patients with late-life depression who have not responded to standard antidepressant therapy. Participants will receive either active tDCS or a sham treatment to assess improvements in depressive symptoms. The study aims to provide insights into the potential of tDCS as a safe and effective alternative for those who are resistant to or intolerant of traditional pharmacotherapy. The focus is on the prefrontal cortex, which is believed to play a crucial role in mood regulation.

Why it matters

Potential benefit: If successful, this approach could offer a new, non-invasive treatment option for elderly patients suffering from depression who do not respond to medications.

How similar studies have gone: Previous studies have shown promise for tDCS in treating depression, but this specific application in the elderly population is less explored and may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants who meet the criteria of major depression defined by DSM-5 criteria
2. Participants will be non-responders and taking an antidepressant of adequate dose and for ≥4 weeks in the current episode which has not led to sufficient clinical improvement (defined as a minimum level of 2 on the ATHF); or can't tolerate the adverse effects of antidepressant in the current episode
3. Ambulatory participants with or without any aiding device

Exclusion Criteria:

1. An urgent risk of suicide or severe depression
2. A history of ineffectiveness with tDCS
3. People who are clinically contraindicated to receive tDCS intervention or MRI assessment, such as having any brain lesion, intracranial implants (clips, cochlear implants), a tattoo or metal embedded in their scalp or brain
4. Any instable medical condition
5. A history of epilepsy,
6. A history of substance use (within one year)
7. People with dementia or psychotic disorder.
8. Any condition which would make the subject unsuitable for the study under the physician's assessment.

Where it's running

  • TaipeiVGH
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.